USD 4.92
(-2.19%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 123.34 Billion EUR | -1.23% |
2022 | 124.87 Billion EUR | 3.86% |
2021 | 120.24 Billion EUR | 2.73% |
2020 | 117.04 Billion EUR | -7.3% |
2019 | 126.25 Billion EUR | -0.02% |
2018 | 126.28 Billion EUR | 68.18% |
2017 | 75.08 Billion EUR | -8.7% |
2016 | 82.23 Billion EUR | 11.26% |
2015 | 73.91 Billion EUR | 5.24% |
2014 | 70.23 Billion EUR | 36.86% |
2013 | 51.31 Billion EUR | -0.04% |
2012 | 51.33 Billion EUR | -2.71% |
2011 | 52.76 Billion EUR | 2.44% |
2010 | 51.5 Billion EUR | 0.91% |
2009 | 51.04 Billion EUR | -2.8% |
2008 | 52.51 Billion EUR | 2.21% |
2007 | 51.37 Billion EUR | -8.07% |
2006 | 55.89 Billion EUR | 52.31% |
2005 | 36.69 Billion EUR | -2.86% |
2004 | 37.77 Billion EUR | 1.06% |
2003 | 37.37 Billion EUR | -10.42% |
2002 | 41.72 Billion EUR | 12.47% |
2001 | 37.1 Billion EUR | 1.51% |
2000 | 36.55 Billion EUR | 16.86% |
1999 | 31.27 Billion EUR | 6.47% |
1998 | 29.37 Billion EUR | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q1 | 119.88 Billion EUR | -2.81% |
2024 Q2 | 119.85 Billion EUR | -0.02% |
2023 Q4 | 123.34 Billion EUR | 5.2% |
2023 Q1 | 125.05 Billion EUR | 0.14% |
2023 Q3 | 117.24 Billion EUR | -3.64% |
2023 Q2 | 121.66 Billion EUR | -2.71% |
2023 FY | 123.34 Billion EUR | -1.23% |
2022 Q3 | 131.01 Billion EUR | 1.72% |
2022 Q2 | 128.79 Billion EUR | 2.39% |
2022 FY | 124.87 Billion EUR | 3.86% |
2022 Q1 | 125.78 Billion EUR | 4.61% |
2022 Q4 | 124.87 Billion EUR | -4.68% |
2021 Q2 | 114.42 Billion EUR | -3.66% |
2021 FY | 120.24 Billion EUR | 2.73% |
2021 Q3 | 116.54 Billion EUR | 1.85% |
2021 Q1 | 118.77 Billion EUR | 1.48% |
2021 Q4 | 120.24 Billion EUR | 3.17% |
2020 Q2 | 123.66 Billion EUR | -1.44% |
2020 Q3 | 119.52 Billion EUR | -3.35% |
2020 Q4 | 117.04 Billion EUR | -2.07% |
2020 FY | 117.04 Billion EUR | -7.3% |
2020 Q1 | 125.47 Billion EUR | -0.62% |
2019 Q2 | 128.38 Billion EUR | -1.4% |
2019 Q4 | 126.25 Billion EUR | -3.45% |
2019 FY | 126.25 Billion EUR | -0.02% |
2019 Q3 | 130.76 Billion EUR | 1.85% |
2019 Q1 | 130.2 Billion EUR | 3.1% |
2018 FY | 126.28 Billion EUR | 68.18% |
2018 Q4 | 126.28 Billion EUR | -2.45% |
2018 Q3 | 129.45 Billion EUR | -5.18% |
2018 Q2 | 136.53 Billion EUR | 81.09% |
2018 Q1 | 75.39 Billion EUR | 0.41% |
2017 Q2 | 82.64 Billion EUR | -2.84% |
2017 Q3 | 76.71 Billion EUR | -7.18% |
2017 Q4 | 75.08 Billion EUR | -2.12% |
2017 FY | 75.08 Billion EUR | -8.7% |
2017 Q1 | 85.05 Billion EUR | 3.42% |
2016 FY | 82.23 Billion EUR | 11.26% |
2016 Q4 | 82.23 Billion EUR | 7.45% |
2016 Q1 | 76.62 Billion EUR | 3.67% |
2016 Q3 | 76.53 Billion EUR | 1.4% |
2016 Q2 | 75.47 Billion EUR | -1.51% |
2015 Q3 | 74.47 Billion EUR | -1.52% |
2015 FY | 73.91 Billion EUR | 5.24% |
2015 Q4 | 73.91 Billion EUR | -0.74% |
2015 Q1 | 76.64 Billion EUR | 9.12% |
2015 Q2 | 75.62 Billion EUR | -1.33% |
2014 Q4 | 70.23 Billion EUR | 15.87% |
2014 Q1 | 56.45 Billion EUR | 10.02% |
2014 Q2 | 54.93 Billion EUR | -2.69% |
2014 Q3 | 60.61 Billion EUR | 10.33% |
2014 FY | 70.23 Billion EUR | 36.86% |
2013 Q3 | 51.89 Billion EUR | -2.39% |
2013 Q4 | 51.31 Billion EUR | -1.11% |
2013 FY | 51.31 Billion EUR | -0.04% |
2013 Q1 | 52.87 Billion EUR | 2.99% |
2013 Q2 | 53.16 Billion EUR | 0.56% |
2012 Q4 | 51.33 Billion EUR | -2.86% |
2012 Q2 | 52.33 Billion EUR | -3.64% |
2012 Q3 | 52.84 Billion EUR | 0.97% |
2012 Q1 | 54.31 Billion EUR | 2.94% |
2012 FY | 51.33 Billion EUR | -2.71% |
2011 FY | 52.76 Billion EUR | 2.44% |
2011 Q4 | 52.76 Billion EUR | 1.63% |
2011 Q3 | 51.92 Billion EUR | 1.7% |
2011 Q2 | 51.05 Billion EUR | -1.48% |
2011 Q1 | 51.82 Billion EUR | 0.61% |
2010 Q3 | 52.18 Billion EUR | -4.56% |
2010 FY | 51.5 Billion EUR | 0.91% |
2010 Q2 | 54.67 Billion EUR | 2.25% |
2010 Q4 | 51.5 Billion EUR | -1.3% |
2010 Q1 | 53.47 Billion EUR | 4.76% |
2009 Q4 | 51.04 Billion EUR | 0.0% |
2009 FY | 51.04 Billion EUR | -2.8% |
2008 Q1 | 51.99 Billion EUR | 1.2% |
2008 Q2 | 51.43 Billion EUR | -1.08% |
2008 FY | 52.51 Billion EUR | 2.21% |
2008 Q4 | 52.51 Billion EUR | -0.29% |
2008 Q3 | 52.66 Billion EUR | 2.39% |
2007 Q2 | 53.39 Billion EUR | -6.24% |
2007 FY | 51.37 Billion EUR | -8.07% |
2007 Q4 | 51.37 Billion EUR | -0.61% |
2007 Q1 | 56.95 Billion EUR | 1.9% |
2007 Q3 | 51.69 Billion EUR | -3.2% |
2006 Q1 | 36.41 Billion EUR | -0.78% |
2006 Q4 | 55.89 Billion EUR | -1.43% |
2006 Q3 | 56.7 Billion EUR | 0.84% |
2006 FY | 55.89 Billion EUR | 52.31% |
2006 Q2 | 56.22 Billion EUR | 54.43% |
2005 Q3 | 36.36 Billion EUR | 1.76% |
2005 Q4 | 36.69 Billion EUR | 0.91% |
2005 FY | 36.69 Billion EUR | -2.86% |
2005 Q1 | 35.44 Billion EUR | -6.17% |
2005 Q2 | 35.73 Billion EUR | 0.82% |
2004 Q3 | 37.08 Billion EUR | -0.68% |
2004 Q1 | 38.08 Billion EUR | 1.89% |
2004 FY | 37.77 Billion EUR | 1.06% |
2004 Q4 | 37.77 Billion EUR | 1.87% |
2004 Q2 | 37.33 Billion EUR | -1.98% |
2003 FY | 37.37 Billion EUR | -10.42% |
2003 Q4 | 37.37 Billion EUR | -5.88% |
2003 Q3 | 39.71 Billion EUR | -2.06% |
2003 Q2 | 40.55 Billion EUR | -3.58% |
2003 Q1 | 42.05 Billion EUR | 0.79% |
2002 Q3 | 44.42 Billion EUR | -0.43% |
2002 Q4 | 41.72 Billion EUR | -6.08% |
2002 Q1 | 38.12 Billion EUR | 2.76% |
2002 FY | 41.72 Billion EUR | 12.47% |
2002 Q2 | 44.62 Billion EUR | 17.04% |
2001 Q2 | 39.28 Billion EUR | 2.55% |
2001 Q1 | 38.3 Billion EUR | 0.0% |
2001 Q4 | 37.1 Billion EUR | -8.64% |
2001 Q3 | 40.61 Billion EUR | 3.37% |
2001 FY | 37.1 Billion EUR | 1.51% |
2000 FY | 36.55 Billion EUR | 16.86% |
1999 FY | 31.27 Billion EUR | 6.47% |
1998 FY | 29.37 Billion EUR | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
AstraZeneca PLC | 100.97 Billion USD | -22.152% |
Bristol-Myers Squibb Company PFD CONV 2 | 95.15 Billion USD | -29.619% |
CSPC Pharmaceutical Group Limited | 6.52 Billion USD | -1790.615% |
Clarus Therapeutics Holdings, Inc. | 51.7 Million USD | -238439.491% |
Novartis AG | 99.94 Billion USD | -23.412% |
PT Kalbe Farma Tbk. | 1.75 Billion USD | -6913.195% |